PubMed
Open access
Impact Factor 2

SAGE Publications

Multiple Sclerosis Journal - Experimental, Translational and Clinical

In PubMed through PubMed Central. Fully open access. Published by SAGE Publications.

This open access journal covers experimental, translational and clinical research across multiple sclerosis. It includes emerging observations, outcome measurement, pilot trials, geographically focused validation and specialised research areas.
Reviewed byDr Robert BaxterDr Robert Baxter· Junior Clinical Fellow, Acute Medical Unit· Updated 15 Nov 2026

Publishing in Multiple Sclerosis Journal - Experimental, Translational and Clinical

Multiple Sclerosis Journal Experimental, Translational and Clinical publishes open access research across experimental, translational and clinical multiple sclerosis. Its scope includes emerging findings with translational potential, early validation of clinical outcome measures, pilot trials, geographically focused validation and specialised research topics.

The journal accepts original research, systematic and traditional reviews, case and short reports, letters, viewpoints, future perspectives, editorials, and invited book and meeting reviews. Every accepted article carries an article processing charge, although institutional discounts and waivers may apply, and there is no submission fee. The median first decision is six days, the acceptance rate is 45.3%, and peer review is single anonymised.

Free subscriber access

Free with a subscription: the author guide in one place

Word limits, abstract lengths and fees for each article type, and a checklist before you submit. Enter your email to unlock this journal and every other guide.

  • Original research paper

    Original experimental, translational or clinical research with a structured abstract.

    Words
    3,000
    Abstract
    200
    Figures & tables
    —
    References
    35
    Structured abstract
  • Systematic reviews and meta-analyses

    Critical reviews of clinically or scientifically important topics following PRISMA or MOOSE.

    Words
    4,000
    Abstract
    200
    Figures & tables
    —
    References
    45
    Follow PRISMA or MOOSE
  • Traditional review

    Narrative reviews of topics relevant to multiple sclerosis research and care.

    Words
    3,500
    Abstract
    200
    Figures & tables
    —
    References
    45
  • Case report or short report

    Brief reports illustrating an important clinical or scientific point.

    Words
    1,000
    Abstract
    100
    Figures & tables
    2
    References
    10
  • Letter to the Editor

    Brief correspondence on published papers or other topics relevant to the journal.

    Words
    500
    Abstract
    —
    Figures & tables
    —
    References
    5
  • Personal viewpoint

    Discussion pieces offering new ideas or questioning significant multiple sclerosis research.

    Words
    1,500
    Abstract
    —
    Figures & tables
    2
    References
    10
  • Future perspective

    Group perspectives on improving or updating important areas of multiple sclerosis research.

    Words
    1,500
    Abstract
    —
    Figures & tables
    2
    References
    10
  • Editorial

    Invited commentary on topics connected with papers in an issue.

    Words
    1,000
    Abstract
    —
    Figures & tables
    —
    References
    10
  • Book and meeting review

    Invited reviews of relevant books and scientific meetings.

    Words
    —
    Abstract
    —
    Figures & tables
    —
    References
    —

The article processing charge is US$3,200 plus VAT where applicable. Institutional discounts and full or partial waivers may be available. There is no submission charge.

Before you submit

  • Upload the relevant EQUATOR reporting checklist with the manuscript.
  • Register clinical trials before first participant enrolment and include registry details in the abstract.
  • Use a structured abstract of no more than 200 words for original research.
  • Remove identifying details from the manuscript and provide them on a separate title page.
  • Submit tables as separate Word files and figures as separate image files.

Present it first.

Similar journals.

Frequently asked

Is Multiple Sclerosis Journal - Experimental, Translational and Clinical indexed in PubMed?
Yes, through PubMed Central. Its articles are deposited in PMC and appear in PubMed with a PMID; it is not indexed in MEDLINE.
How much does it cost to publish in Multiple Sclerosis Journal - Experimental, Translational and Clinical?
Not stated by the journal.
Does Multiple Sclerosis Journal - Experimental, Translational and Clinical accept case reports?
Yes. Multiple Sclerosis Journal - Experimental, Translational and Clinical publishes case reports.
What is the Impact Factor of Multiple Sclerosis Journal - Experimental, Translational and Clinical?
Multiple Sclerosis Journal - Experimental, Translational and Clinical states an Impact Factor of 2 for 2025.
How long does Multiple Sclerosis Journal - Experimental, Translational and Clinical take to decide?
About 6 days from submission to first decision.
What is the acceptance rate of Multiple Sclerosis Journal - Experimental, Translational and Clinical?
Multiple Sclerosis Journal - Experimental, Translational and Clinical states that it accepts 45.3% of submissions.
What kind of peer review does Multiple Sclerosis Journal - Experimental, Translational and Clinical use?
Single-blind peer review.

PubMed via PMC · Open access · First decision in 6 days

Accepted work
Original research · Case report · Systematic review · Literature review
Acceptance rate
45.3%
Peer review
Single-blind
Access
Free to read
Author guide

Checked against the journal’s author guide · updated 15 Nov 2026